Angela Volkert
Vice President, Clinical Research at Hemab Therapeutics
Angela Volkert is a Vice President, Clinical Research at Hemab Therapeutics.
Hemab Therapeutics: Pioneering therapies for bleeding disorders that medicine left behind.
Hemab Therapeutics's latest round on file is a Series C.
Adamlead has Angela's work email on file, and it has been verified. It's shown masked here and unlocked in the app.
- Work email
- a***@hemab.comVerified
- Company
Hemab Therapeuticshemab.com
The full address is unlocked in the app with Lifetime access.
More people at Hemab Therapeutics
- Associate DirectorClinical OperationsUnverified
- Benny SorensenChief Executive OfficerVerified
- Bernd SchadenDirector, Supply Chain, CMCVerified
- Christina GrosseOffice/HR Manager and Executive Assistant to the Head of CMC & ManufacturingVerified
- Erik BjornsonVice President, Regulatory AffairsVerified
- Jennifer DupeeExecutive Assistant/Office ManagerUnverified
- Joe VogelSenior Director, Program LeadershipVerified
- Karen WeisbachChief People and Culture OfficerVerified
- Kathryn ZwetchkenbaumManager, Human Resources and Executive AssistantVerified
- Leyna ChoSenior Clinical Trial AssociateVerified
- Lisa JohnsenAssociate Director, Medical WritingVerified
- Louise Almsgaard HeltSenior Finance Business PartnerVerified
28 people on file at Hemab Therapeutics.
Is this you? Ask for your details to be removed.